Moreover, in the Multicentre Long-Term Cardiovascular Outcomes Trial, GLP-1RA decreased all-cause mortality, vascular mortality and non-fatal heart attacks in participants [5]
The stated purpose is to detect immune activation early
YL: Conceptualization, Supervision, Writing review & editing, Data curation, Investigation
This article summarizes the milestones in the development of semaglutide leading to this first approval for type 2 diabetes
your prescribing doctor would likely not debate between Wegovy and Mounjaro because those brands are prescribed for two different purposes (weight loss and diabetes, respectively), even though the active medications (semaglutide and tirzepatide) are each prescribed for both weight loss and diabetes